Companies / Sagimet Biosciences Inc.

Sagimet Biosciences Inc.

Nasdaq: SGMTCIK 1400118FOSTER CITY, CA

Financials · FY2023

Revenue$2.00M
Net income$-51.04M
Total debt—
Cash$165.90M
Diluted EPS$-1.58
Shares outstanding62.2M

Ownership

62.2M shares outstanding · as of Aug 4, 2026
1.9%Insiders
Ownership
99.1%Class A
Share classes
Class A99.09%
Class B0.91%
Insiders1.91%1,187,876
Institutions36.66%22,784,292
Public float61.43%38,186,485

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 11

View all →
Insider% of sharesShares
Happel DavidCEOPresident & CEO · Director
1.30%805,621
Rozek ElizabethChief Legal & Admin. Officer
0.38%234,959
Martins Eduardo BrunoChief Medical Officer
0.24%147,296
Chauche ThierryFormerChief Financial Officer
0.10%59,688
Grammer Elizabeth aDirector
——
Grauer AndreasFormerChief Medical Officer
——
Hoelscher Paul W.Director
——
Jarrett JenniferDirector
——
Kemble GeorgeDirector
——
Phillips Anne M.Director
——

Institutional holders 92

View all →
HolderValue% of shares
BlackRock, Inc.$50.83M10.58%
State Street Corporation$15.42M3.21%
Vanguard Group Inc$7.46M2.03%
Blue Owl Capital Holdings LP$7.36M2.00%
Affinity Asset Advisors, LLC$6.80M1.85%
Woodline Partners LP$5.93M1.61%
Marshall Wace, LLP$5.04M1.55%
Baker Bros. Advisors LP$4.98M1.53%
Millennium Management LLC$4.51M1.39%
Hhlr Advisors, Ltd.$4.29M1.17%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 10, 2026Happel David
CEO
SellSeries A Common Stock$64.9K-12K
-1.75%
677,621
1.09% of shares
low
Feb 10, 2026Martins Eduardo Bruno
Executive
SellSeries A Common Stock$19.5K-4K
-3.40%
103,296
0.17% of shares
low
Feb 10, 2026Rozek Elizabeth
Executive
SellSeries A Common Stock$14.1K-3K
-1.35%
190,959
0.31% of shares
low
Feb 10, 2026Chauche Thierry
Executive
SellSeries A Common Stock$7.0K-1K
-7.72%
15,688
0.03% of shares
low
Feb 19, 2026Martins Eduardo Bruno
Executive
GrantSeries A Common Stock$0+44K
+42.60%
147,296
0.24% of shares
low
Feb 19, 2026Happel David
CEO
GrantSeries A Common Stock$0+128K
+18.89%
805,621
1.30% of shares
low
Feb 19, 2026Rozek Elizabeth
Executive
GrantSeries A Common Stock$0+44K
+23.04%
234,959
0.38% of shares
low
Feb 19, 2026Chauche Thierry
Executive
GrantSeries A Common Stock$0+44K
+280.47%
59,688
0.10% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
SGMTCommon StockEquity786700104BBG0020584Y9